New York State Common Retirement Fund reduced its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 7.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 849,410 shares of the conglomerate's stock after selling 64,461 shares during the quarter. New York State Common Retirement Fund owned about 0.12% of Danaher worth $174,129,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Norges Bank bought a new position in Danaher in the fourth quarter valued at approximately $2,130,740,000. GAMMA Investing LLC boosted its stake in Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after acquiring an additional 1,863,381 shares during the last quarter. Two Sigma Advisers LP boosted its stake in Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after acquiring an additional 1,601,800 shares during the last quarter. Capital World Investors boosted its stake in Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after acquiring an additional 1,566,658 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its stake in Danaher by 460.6% in the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after acquiring an additional 1,107,998 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Stock Down 0.3%
Shares of NYSE:DHR traded down $0.71 during midday trading on Friday, reaching $204.80. 2,369,010 shares of the company were exchanged, compared to its average volume of 3,508,130. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The stock has a fifty day simple moving average of $196.05 and a two-hundred day simple moving average of $206.30. The firm has a market cap of $146.57 billion, a PE ratio of 39.77, a P/E/G ratio of 2.88 and a beta of 0.77.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's payout ratio is currently 24.85%.
Insider Buying and Selling at Danaher
In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president directly owned 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the stock. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Argus reduced their price objective on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Guggenheim reissued a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $248.43.
View Our Latest Research Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
